随着使用量的增加，一些美国雇主将在 2027 年取消 GLP-1 肥胖药物的覆盖范围 - 路透中文网

Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases - Reuters

Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases Reuters PSG report examines payers and employers’ attitudes towards GLP-1 coverage, unbundling’ PBM models Fierce Healthcare Employers are rethinking pharmacy benefits: 5 things to know Modern Healthcare U.S. employers dropping GLP-1 weight loss drug coverage in 2027 Yahoo Finance Can California afford to cover Ozempic for public employees? CalMatters

这条新闻具备可验证事件线索，可继续观察是否形成 Yes/No 预测问题。

同主题新闻会帮助 Google 识别事件簇，也让用户继续进入可交易话题。